title: n-3 fatty acid ethyl ester administration to healthy subjects and to hypertriglyceridemic patients reduces tissue factor activity in adherent monocytes.
abstract: n-3 Fatty acids are known to influence several functions of monocytes, including adhesion, cytokine synthesis, and superoxide generation. Monocytes express tissue factor, a membrane-bound glycoprotein, that acts as a catalyst in the coagulation cascade. In this study we evaluated the effects of administration of n-3 fatty acid ethyl esters to healthy volunteers and to hypertriglyceridemic patients on tissue factor activity (TF activity) in adherent monocytes. n-3 Fatty acids containing 75% eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) (ratio of EPA to DHA, 1.34) were administered (3 g/d) to normal volunteers for 18 weeks. In addition, the effects of this treatment were evaluated in 30 hypertriglyceridemic patients for 24 weeks by using a double-blind, placebo-controlled study. TF activity in adherent monocytes was evaluated with a one-stage clotting assay. Plasma and monocyte fatty acid compositions were determined by gas-liquid chromatography. In healthy volunteers, n-3 fatty acids significantly reduced TF activity in adherent monocytes either in the unstimulated condition or after exposure to endotoxin. The inhibitory effect was observed after 12 weeks of treatment and was more pronounced after 18 weeks (> 70%, P < .001 versus baseline). Concomitantly, levels of EPA and DHA increased in plasma and monocyte lipids. Interestingly, after stopping treatment, monocyte TF activity remained inhibited for at least 14 weeks. Treatment with n-3 fatty acids for 24 weeks also resulted in a significant reduction of TF activity in adherent monocytes from hypertriglyceridemic patients (-31% and -40% in unstimulated and endotoxin-stimulated cells; P < .05 versus baseline).(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Institute of Pharmacological Sciences, E. Grossi Paoletti Center, University of Milan, Italy.
authors.forename: E
authors.initials: E
authors.lastname: Tremoli
authors.forename: S
authors.initials: S
authors.lastname: Eligini
authors.forename: S
authors.initials: S
authors.lastname: Colli
authors.forename: P
authors.initials: P
authors.lastname: Maderna
authors.forename: P
authors.initials: P
authors.lastname: Risè
authors.forename: F
authors.initials: F
authors.lastname: Pazzucconi
authors.forename: F
authors.initials: F
authors.lastname: Marangoni
authors.forename: C R
authors.initials: CR
authors.lastname: Sirtori
authors.forename: C
authors.initials: C
authors.lastname: Galli
mesh_terms: D000328:Adult; D002448:Cell Adhesion; D004281:Docosahexaenoic Acids / Q000494:pharmacology*; D004311:Double-Blind Method; D015118:Eicosapentaenoic Acid / Q000494:pharmacology*; D005227:Fatty Acids / Q000097:blood; D005260:Female; D006801:Humans; D015228:Hypertriglyceridemia / Q000097:blood*; D008297:Male; D009000:Monocytes / Q000502:physiology*; D010919:Placebos; D012016:Reference Values; D013925:Thromboplastin / Q000378:metabolism
chemical_list: D005227:Fatty Acids; D010919:Placebos; D004281:Docosahexaenoic Acids; D013925:Thromboplastin; D015118:Eicosapentaenoic Acid